Endometrial Cancer (cont.)

Medical Author:

William T Creasman, MD

Medical Editor:

Jerry R. Balentine, DO, FACEP

Jerry R. Balentine, DO, FACEP

Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.

View Full Profile

Follow-up

After therapy has been completed, the woman undergoes testing to determine how effective the treatment has been. If the CA 125 (tumor marker) level was high at the time of diagnosis, this level will be checked again to see whether it returned to a normal level after treatment. A woman may also undergo other blood tests and imaging tests that provide clues to disease recurrence. A doctor requires a woman to be tested and examined regularly so that disease recurrence (if it happens) can be found early. The doctor will discuss a schedule for these follow-up visits with the woman and her family members.

estrogens.

Some risk factors cannot be avoided. For example, neither a previous cancer of the breast, colon, or ovaries nor a family history of these cancers can be avoided. Early puberty and late menopause are part of a person's genetic makeup and cannot be changed.